_PRIVATE_LIMITED.webp)
Dhanvantary Bioscience Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.47 Cr
- Revenue Growth 205.58%
- Profit Growth 63.91%
- Ebitda 59.63%
- Net Worth 68.43%
- Total Assets 548.81%
About Dhanvantary Bioscience
Dhanvantary Bioscience Private Limited (DBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 December 2017 (Seven years and two months 9 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Corporate was formerly known as Dhanvantary Bioscience (Opc) Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹6.47 Cr.
Pranab Meur and Rinki Meur serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
- CIN/LLPIN
U74999WB2017PTC223914
- Company No.
223914
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Dhanvantary Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranab Meur  | Director | 18-Dec-2017 | Current |
| Rinki Meur | Director | 05-Dec-2020 | Current |
Financial Performance of Dhanvantary Bioscience.
Dhanvantary Bioscience Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 205.58% increase. The company also saw a substantial improvement in profitability, with a 63.91% increase in profit. The company's net worth Soared by an impressive increase of 68.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhanvantary Bioscience?
In 2020, Dhanvantary Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹64.72 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 6.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jul 2021 | Hdfc Bank Limited | ₹5.87 Cr | Open |
| 27 Nov 2020 | Hdfc Bank Limited | ₹6.00 M | Open |
How Many Employees Work at Dhanvantary Bioscience?
Dhanvantary Bioscience has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhanvantary Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanvantary Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.